4 BioSpace (PR Newswire)Announcement on completion of the Phase 2b obesity trial of AOD-9604
Clinical Update 8/25/2023 Zyflamend for Joint Pain
MYCN is a transcription factor belonging to the highly homologous MYC -family of cellular oncogenes, ubiquitously expressed in mammals
The maximum penalty is a fine of $2,200 and/or imprisonment for 6 months. TGA warns of enhanced monitoring for safety and legal concerns On 13 April this year, the Therapeutic Goods Administration (TGA) issued a safety advisory regarding the import, supply, compounding, and advertising of unapproved peptide products
For example, in a study by Fu et al ., the TAT-KLA peptide was conjugated to the BRBP1 peptide, which was previously identified for its affinity toward the MDA-MB-231 cell line, to enhance its specificity against tumor cells
The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has published guidelines on the verification pathway for new medicine applications
